Compare LRMR & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LRMR | IBEX |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 448.0M |
| IPO Year | 2014 | 2017 |
| Metric | LRMR | IBEX |
|---|---|---|
| Price | $4.02 | $37.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | $16.50 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 908.7K | 92.8K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.26 |
| EPS | N/A | ★ 2.54 |
| Revenue | N/A | ★ $558,273,000.00 |
| Revenue This Year | N/A | $14.13 |
| Revenue Next Year | $1,816.14 | $5.68 |
| P/E Ratio | ★ N/A | $15.42 |
| Revenue Growth | N/A | ★ 9.77 |
| 52 Week Low | $2.72 | $25.94 |
| 52 Week High | $6.42 | $42.99 |
| Indicator | LRMR | IBEX |
|---|---|---|
| Relative Strength Index (RSI) | 46.59 | 51.20 |
| Support Level | $3.57 | $36.51 |
| Resistance Level | $4.21 | $39.81 |
| Average True Range (ATR) | 0.17 | 1.18 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 29.03 | 52.22 |
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.